Rich Rubino | Chief Financial Officer |
Vince Anido | Chairman and Chief Executive Officer |
Tom Mitro | President and Chief Operating Officer |
John LaRocca | General Counsel |
Adnan Butt | Guggenheim Securities |
Annabel Samimy | Stifel |
Serge Belanger | Needham & Company |
Ken Cacciatore | Cowen & Company |
Elemer Piros | Cantor |
Oren Livnat | H.C. Wainwright |
Good afternoon, ladies and gentlemen. Thank you for standing by and welcome to the Aerie Pharmaceuticals Second Quarter 2018 Earnings conference call. [Operator Instructions] Today’s conference call will be recorded. It is now my pleasure to turn the floor over to Aerie’s Chief Financial Officer, Rich Rubino. Please go ahead sir.